• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存分析中的标记过程。

Marker processes in survival analysis.

作者信息

Jewell N P, Kalbfleisch J D

机构信息

Department of Statistics, University of California, Berkeley 94720, USA.

出版信息

Lifetime Data Anal. 1996;2(1):15-29. doi: 10.1007/BF00128468.

DOI:10.1007/BF00128468
PMID:9384646
Abstract

In the development of many diseases there are often associated variables which continuously measure the progress of an individual towards the final expression of the disease (failure). Such variables are stochastic processes, here called marker processes, and, at a given point in time, they may provide information about the current hazard and subsequently on the remaining time to failure. Here we consider a simple additive model for the relationship between the hazard function at time t and the history of the marker process up until time t. We develop some basic calculations based on this model. Interest is focused on statistical applications for markers related to estimation of the survival distribution of time to failure, including (i) the use of markers as surrogate responses for failure with censored data, and (ii) the use of markers as predictors of the time elapsed since onset of a survival process in prevalent individuals. Particular attention is directed to potential gains in efficiency incurred by using marker process information.

摘要

在许多疾病的发展过程中,通常存在相关变量,这些变量持续衡量个体朝着疾病最终表现(衰竭)发展的进程。此类变量是随机过程,在此称为标记过程,并且在给定时间点,它们可以提供有关当前风险的信息,以及随后关于剩余衰竭时间的信息。在此,我们考虑一个关于时间(t)时的风险函数与直至时间(t)的标记过程历史之间关系的简单加法模型。我们基于此模型进行一些基本计算。重点在于与衰竭时间生存分布估计相关的标记的统计应用,包括(i)将标记用作删失数据情况下衰竭的替代反应,以及(ii)将标记用作现患个体中自生存过程开始以来所经过时间的预测指标。特别关注利用标记过程信息所带来的潜在效率提升。

相似文献

1
Marker processes in survival analysis.生存分析中的标记过程。
Lifetime Data Anal. 1996;2(1):15-29. doi: 10.1007/BF00128468.
2
Models for residual time to AIDS.艾滋病剩余时间模型。
Lifetime Data Anal. 1996;2(1):31-49. doi: 10.1007/BF00128469.
3
Simple estimation procedures for regression analysis of interval-censored failure time data under the proportional hazards model.比例风险模型下区间删失失效时间数据回归分析的简单估计程序。
Lifetime Data Anal. 2015 Jan;21(1):138-55. doi: 10.1007/s10985-013-9282-4. Epub 2013 Sep 27.
4
Failure inference from a marker process based on a bivariate Wiener model.基于二元维纳模型的标记过程的失效推断
Lifetime Data Anal. 1998;4(3):229-51. doi: 10.1023/a:1009617814586.
5
Testing the proportional odds model for interval-censored data.检验区间删失数据的比例优势模型。
Lifetime Data Anal. 2007 Mar;13(1):37-50. doi: 10.1007/s10985-006-9029-6.
6
Survival models based on the Ornstein-Uhlenbeck process.基于奥恩斯坦-乌伦贝克过程的生存模型。
Lifetime Data Anal. 2004 Dec;10(4):407-23. doi: 10.1007/s10985-004-4775-9.
7
Bayesian nonparametric dynamic hazard rates in evolutionary life tables.贝叶斯非参数动态危险率在进化生命表中的应用。
Lifetime Data Anal. 2022 Apr;28(2):319-334. doi: 10.1007/s10985-022-09551-x. Epub 2022 Mar 17.
8
On the analysis of life tables for dependent observations.
Stat Med. 1994 Nov 30;13(22):2383-4. doi: 10.1002/sim.4780132209.
9
Frailty models and rank tests.脆弱模型与秩检验。
Lifetime Data Anal. 1998;4(3):209-28. doi: 10.1023/a:1009689630516.
10
Proportional hazards model for interval-censored failure times and time-dependent covariates: application to hazard of HIV infection of injecting drug users in prison.区间删失失效时间和随时间变化协变量的比例风险模型:在监狱中注射吸毒者感染艾滋病毒风险中的应用
Stat Med. 2001 Jun 30;20(12):1855-70. doi: 10.1002/sim.809.

引用本文的文献

1
Comparison of joint modeling and landmarking for dynamic prediction under an illness-death model.疾病死亡模型下动态预测的联合建模与地标法比较
Biom J. 2017 Nov;59(6):1277-1300. doi: 10.1002/bimj.201600235. Epub 2017 May 16.
2
A weighted cumulative sum (WCUSUM) to monitor medical outcomes with dependent censoring.一种用于监测具有相依删失的医学结局的加权累积和(WCUSUM)。
Stat Med. 2014 Aug 15;33(18):3114-29. doi: 10.1002/sim.6139. Epub 2014 Mar 13.
3
Joint analysis of current status and marker data: an extension of a bivariate threshold model.

本文引用的文献

1
Models for residual time to AIDS.艾滋病剩余时间模型。
Lifetime Data Anal. 1996;2(1):31-49. doi: 10.1007/BF00128469.
2
Marker-dependent hazard estimation: an application to AIDS.
Stat Med. 1993 May 15;12(9):843-65. doi: 10.1002/sim.4780120905.
3
Nonparametric methods for survival/sacrifice experiments.生存/牺牲实验的非参数方法。
Biometrics. 1986 Jun;42(2):325-41.
当前状态与标记数据的联合分析:双变量阈值模型的扩展
Int J Biostat. 2008 Oct 16;4(1):Article 21. doi: 10.2202/1557-4679.1122.
4
Models and estimation for systems with recurrent events and usage processes.
Lifetime Data Anal. 2010 Oct;16(4):547-70. doi: 10.1007/s10985-010-9157-x. Epub 2010 Mar 11.
5
Estimating Load-Sharing Properties in a Dynamic Reliability System.估计动态可靠性系统中的负载分担特性。
J Am Stat Assoc. 2005 Jan 1;100(469):262-272. doi: 10.1198/016214504000000863.
6
Regression modeling with recurrent events and time-dependent interval-censored marker data.具有复发事件和时间依存性区间删失标记数据的回归建模
Lifetime Data Anal. 2003 Sep;9(3):275-91. doi: 10.1023/a:1025888820636.
7
Alternative time scales and failure time models.替代时间尺度和失效时间模型。
Lifetime Data Anal. 2000 Jun;6(2):157-79. doi: 10.1023/a:1009616111968.
8
Some remarks on failure-times, surrogate markers, degradation, wear, and the quality of life.关于失效时间、替代指标、退化、磨损及生活质量的一些评论。
Lifetime Data Anal. 1999 Dec;5(4):307-14. doi: 10.1023/a:1009684008455.
9
Failure inference from a marker process based on a bivariate Wiener model.基于二元维纳模型的标记过程的失效推断
Lifetime Data Anal. 1998;4(3):229-51. doi: 10.1023/a:1009617814586.
4
Biases in prevalent cohorts.现患队列中的偏倚。
Biometrics. 1987 Dec;43(4):739-49.
5
Surrogate endpoints in clinical trials: definition and operational criteria.临床试验中的替代终点:定义与操作标准。
Stat Med. 1989 Apr;8(4):431-40. doi: 10.1002/sim.4780080407.
6
Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group.男同性恋者1型人类免疫缺陷病毒(HIV-1)血清转化后无获得性免疫缺陷综合征(AIDS)的时间。多中心艾滋病队列研究组。
Am J Epidemiol. 1989 Sep;130(3):530-9. doi: 10.1093/oxfordjournals.aje.a115367.
7
Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. Multicentre AIDS Cohort Study.
Stat Med. 1990 May;9(5):505-14. doi: 10.1002/sim.4780090504.